Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04670328
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2020-12-14
Brief Title:
Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity
Sponsor:
FMH College of Medicine and Dentistry
Organization:
FMH College of Medicine and Dentistry
Study Overview
Official Title:
Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity
Status:
COMPLETED
Status Verified Date:
2020-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The hemostatic abnormalities in COVID-19 are related with disease progression severity and mortality The Objective of our study is to evaluate the role of hematological parameters in determination of COVID-19 disease severity
Detailed Description:
Objective
COVID-19 virus involves respiratory as well as other body systems including cardiovascular gastrointestinal neurological immunological and hematopoietic system Patient of covid-19 pneumonia presents with wide range of hemostatic abnormalities These hemostatic abnormalities in COVID-19 are related with disease progression severity and mortality The Objective of our study is to evaluate the role of hematological parameters in determination of COVID-19 disease severity
Material and Method
This was a retrospective study conducted in Department of Pathology and Department of medicine FMH college of Medicine and Dentistry from May 2020 to July 2020 Total of 101 confirmed cases of covid-19 disease both genders between 17 to 75-year age were included Hematological parameters were compared in mild moderate severe and critical disease group Continuous variables were analyzed by using non parametric Kruskal Wallis test while categorical variables were analyzed by chi-square test
COVID-19 virus involves respiratory as well as other body systems including cardiovascular gastrointestinal neurological immunological and hematopoietic system Patient of covid-19 pneumonia presents with wide range of hemostatic abnormalities These hemostatic abnormalities in COVID-19 are related with disease progression severity and mortality The Objective of our study is to evaluate the role of hematological parameters in determination of COVID-19 disease severity
Material and Method
This was a retrospective study conducted in Department of Pathology and Department of medicine FMH college of Medicine and Dentistry from May 2020 to July 2020 Total of 101 confirmed cases of covid-19 disease both genders between 17 to 75-year age were included Hematological parameters were compared in mild moderate severe and critical disease group Continuous variables were analyzed by using non parametric Kruskal Wallis test while categorical variables were analyzed by chi-square test
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None